Drugs / Polyethylene Glycol Electrolyte
Trials 0
Also used as a comparator or background therapy in 2 trials
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 31 trial | ||||||
| Phase 3 | NCT05465889 Comparator | May 2019 → Jan 2020 | — | Changhai Hospital | Completed | No outcome recorded |
| Phase not applicable1 trial | ||||||
| — | NCT05912114 Comparator | Jun 2023 → Dec 2024 | — | Ningbo No. 1 Hospital | Unknown | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 4 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Polyethylene glycol electrolyte | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05912114 ↗ |
| Known as | PEG | “This randomized controlled trial was designed to compare the efficacy and tolerability of orally administered mannitol and polyethylene glycol (PEG) solutions for repeat...” PMID 41444456 ↗ Dec 20251“3-L split-dose polyethylene glycol (PEG) for bowel preparation before colonoscopy.” PMID 37422241 ↗ Jul 2023 |
| Route | Oral | “Use of oral 1L PEG for remediation of intestinal uncleanliness” NCT05912114 ↗ |